留言
报告导航:研究报告生命科学制药医疗
2014-2016年中国冠脉球囊行业研究报告
字数:3.7万 页数:113 图表数:138
中文电子版:8000元 中文纸版:4000元 中文(电子+纸)版:8500元
英文电子版:2350美元 英文纸版:2500美元 英文(电子+纸)版:2650美元
编号:ZLC-008 发布日期:2014-09 附件:下载

冠脉球囊作为PCI手术中的必备医疗器械,不仅要作为支架的输送系统使用,还要作为置放支架前预扩或后扩使用。因此,冠脉球囊行业的发展与冠脉介入手术的发展息息相关。

随着国民经济的发展和人们生活水平的提高,中国接受冠脉介入术PCI的病例数逐年上升。2013年,中国PCI总例数达454,505例,同比增长16.9%。同期,中国冠脉球囊需求量达到118.6万套,同比增长13.8%。

虽然中国PCI病例数逐年增长,但普及率还很低。2013年中国平均百万人PCI例数为309.42例,而美国约为1800例。这表明中国冠脉介入治疗市场还存在很大的发展空间,冠脉球囊行业的发展前景良好,预计到2016年,中国冠脉球囊的需求量将达182.4万套。

目前,中国冠脉球囊市场仍主要被美敦力、雅培、波士顿、戈德曼、泰尔茂等国外企业占据。不过,中国冠脉球囊本土企业的竞争力正在提高,总体市场份额从2009年的20%提升到了2013年的40%左右。

中国冠脉球囊本土企业包括乐普医疗、微创医疗、山东吉威、垠艺、深圳业聚、心宜医疗、赛诺医疗、北京迪玛克等。其中,乐普医疗、微创医疗、深圳业聚和赛诺医疗既生产与冠脉支架配套的输送用冠脉球囊也生产PTCA球囊,而山东吉威只生产与冠脉支架配套的输送用冠脉球囊,北京迪玛克只生产PTCA球囊。

微创医疗是中国冠脉支架系统市场的领头羊。2014年1月20日,公司宣布正式收购强生旗下的Cordis公司的药物洗脱支架相关资产,收购完成后其药物支架市场份额将提高10%以上。这也将推动公司与冠脉支架配套的冠脉球囊业务发展,目前公司的冠脉球囊产能达20万套以上。

乐普医疗是中国冠脉球囊行业的领先企业。目前公司已具备年产10万套PTCA球囊扩张导管以及冠脉支架配套输送系统17万套的生产能力。

《2014-2016年中国冠脉球囊市场投资报告》主要包括以下内容:
  20120114.gif中国冠脉球囊市场运行环境分析,包括宏观环境、政策环境、医疗卫生水平和中国医疗器械行业现状等;
  20120114.gif中国冠脉球囊市场概述,包括发展现状、发展瓶颈、市场供需、竞争格局及发展前景与预测等;
  20120114.gif中国冠脉球囊市场投资分析,包括有利因素、不利因素、经济效益以及建厂地选择等;
  20120114.gif国外5家、中国9家冠脉球囊企业的经营状况、冠脉球囊业务分析等。
冠脉球囊_副本.jpg


PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore, the development of PTCA balloon industry is closely related to that of PCI.

As national economy develops and people’s living standard improves, the number of patients receiving PCI has been on the rise year by year, and totaled 454,505 cases in China in 2013, up 16.9% from a year earlier. Demand for PTCA balloon during the same period reached 1.186 million sets, rising by 13.8% on a year-on-year basis.

Despite year-on-year growth in the number of PCI cases in China, the penetration is still very low. In 2013, 309.42 per 1 million were people receiving PCI treatment in China, compared with 1800 cases in the United States, showing a vast space for development of the Chinese PCI market and a bright future for PTCA balloon industry. It is expected that China’s demand for PTCA balloon will hit 1.824 million sets by 2016.

At present, the Chinese PTCA balloon market is still dominated by foreign companies, such as Medtronic, Abbott, Boston Scientific, Goodman, Terumo, etc. However, local Chinese PTCA balloon companies are improving their competitiveness, with overall market share rising to about 40% in 2013 as opposed to 20% in 2009.

Local Chinese PTCA balloon companies include Lepu Medical, MicroPort, JW Medical, Yinyi, Neich Medical (Shenzhen), Synexmed, Sino Medical and Demax Medical, of which Lepu Medical, MicroPort, Neich Medical (Shenzhen) and Sino Medical manufacture both PTCA balloon catheter for delivering coronary stent and PTCA balloon, JW Medical manufactures only PTCA balloon for delivering coronary stent, and Demax Medical produces only PTCA balloon.

MicroPort is a bellwether in the Chinese coronary stent system market. On Jan. 20, 2014, MicroPort announced that it would acquire drug-eluting stent-related assets of Cordis under Johnson & Johnson. After the acquisition is completed, MicroPort’s share in drug-eluting stent market will rise by over 10%. This will also promote company’s business development of PTCA balloon for delivering coronary stent. MicroPort now can manufacture more than 200,000 sets of PTCA balloon annually.

Lepu Medical is a leading player in China PTCA balloon industry. The company now has PTCA balloon dilatation catheter capacity of 100,000 sets and coronary stent delivery system capacity of 170,000 sets.

冠脉 英文_副本.jpg

China PTCA Balloon Catheter Market Investment Report, 2014-2016 focuses on the following:
20120114.gifOperating environment of the Chinese PTCA balloon market, including macro environment, policy climate, medical & health care level and status quo of China medical device industry;
20120114.gifOverview of the Chinese PTCA balloon market, covering status quo, development bottlenecks, supply & demand, competitive landscape and development outlook and forecast;
20120114.gifInvestment in the Chinese PTCA balloon market, including favorable and unfavorable factors, economic benefit and site selection of plants;
20120114.gifOperation and PTCA balloon business of 5 foreign and 9 Chinese PTCA balloon companies.

第一章 冠脉球囊行业相关概念
1.1 冠脉球囊定义及分类
1.2 介入医疗器械定义及分类
 
第二章 中国冠脉球囊市场运行环境分析
2.1 宏观环境
2.2 政策环境
2.3 医疗卫生水平
2.4 中国医疗器械行业现状

第三章 中国冠脉球囊市场概述
3.1 发展现状
3.2 发展瓶颈
3.3 市场供需
3.3.1 市场需求
3.3.2 市场供给
3.4 竞争格局
3.5 发展前景与预测

第四章 中国冠脉球囊市场投资分析
4.1 有利因素
4.1.1 国家产业政策大力扶持
4.1.2 享有税收等财政优惠
4.1.3 市场需求不断扩大
4.1.4 市场越来越规范
4.2 不利因素
4.2.1产品降价风险增加
4.2.2 相关生产材料和设备供应不足
4.2.3 国外非关税壁垒的限制
4.3 经济效益分析
4.4 建厂地点选择
4.4.1 成都
4.4.2 杭州
4.5 GMP厂房建设

第五章 国内重点企业分析
5.1 乐普医疗
5.1.1 公司简介
5.1.2 经营状况
5.1.3 营收构成
5.1.4 毛利率
5.1.5 公司冠脉球囊业务
5.1.6 研发与投资
5.1.7 预测与展望
5.2 微创医疗
5.2.1 公司简介
5.2.2 经营状况
5.2.3 营收构成
5.2.4 冠脉球囊业务
5.2.5 研发与投资
5.2.6 预测与展望
5.3 山东吉威
5.3.1 公司简介
5.3.2 冠脉球囊业务
5.4 垠艺
5.4.1 公司简介
5.4.2 冠脉球囊业务
5.5 深圳业聚
5.5.1 公司简介
5.5.2 冠脉球囊业务
5.6 深圳益心达
5.6.1 公司简介
5.6.2 冠脉球囊业务
5.7 心宜医疗
5.7.1 公司简介
5.7.2 冠脉球囊业务
5.8 赛诺医疗
5.8.1 公司简介
5.8.2 冠脉球囊业务
5.9 北京迪玛克
5.9.1 公司简介
5.9.2 冠脉球囊业务

第六章 国外主要企业
6.1 美敦力
6.1.1 公司简介
6.1.2 经营状况
6.1.3 冠脉球囊业务
6.1.4 在华运营
6.2 波士顿科学
6.2.1 公司简介
6.2.2 经营状况
6.2.3 冠脉球囊业务
6.2.4 在华运营
6.3 雅培
6.3.1 公司简介
6.3.2 经营状况
6.3.3 冠脉球囊业务
6.3.4 在华运营
6.4 泰尔茂
6.4.1 公司简介
6.4.2 经营状况
6.4.3 冠脉球囊业务
6.4.4 在华运营
6.5 贝朗
6.5.1 公司简介
6.5.2 经营情况
6.5.3 冠脉球囊业务
6.5.4 在华运营

1. Concepts Related to PTCA Balloon Industry
1.1 Definition and Classification of PTCA Balloon
1.2 Definition and Classification of Interventional Medical Device
 
2. Operating Environment of Chinese PTCA Balloon Market
2.1 Macro Environment
2.2 Policy Climate
2.3 Medical & Health Care Level
2.4 Status Quo of China Medical Device Industry

3. Overview of Chinese PTCA Balloon Market
3.1 Status Quo
3.2 Development Bottleneck
3.3 Supply & Demand
3.3.1 Demand
3.3.2 Supply
3.4 Competitive Landscape
3.5 Development Outlook and Forecast

4. Investment in Chinese PTCA Balloon Market
4.1 Favorable Factors
4.1.1 Strong Support by National Industrial Policy
4.1.2 Financial Incentives
4.1.3 Expanding Market Demand
4.1.4 Increasingly Standardized Market
4.2 Unfavorable Factors
4.2.1 Mounting Risk of Price Drop
4.2.2 Shortage of Related Production Materials and Equipment
4.2.3 Foreign Non-Tariff Barriers
4.3 Economic Benefit
4.4 Site Selection of Plants
4.4.1 Chengdu
4.4.2 Hangzhou
4.5 Construction of GMP Plant

5. Major Chinese Companies
5.1 Lepu Medical
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 PTCA Balloon Business
5.1.6 R&D and Investment
5.1.7 Forecast and Outlook
5.2 MicroPort
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 PTCA Balloon Business
5.2.5 R&D and Investment
5.2.6 Forecast and Outlook
5.3 JW Medical
5.3.1 Profile
5.3.2 PTCA Balloon Business
5.4 Dalian Yinyi
5.4.1 Profile
5.4.2 PTCA Balloon Business
5.5 Neich Medical (Shenzhen)
5.5.1 Profile
5.5.2 PTCA Balloon Business
5.6 SCW Medicath
5.6.1 Profile
5.6.2 PTCA Balloon Business
5.7 Synexmed
5.7.1 Profile
5.7.2 PTCA Balloon Business
5.8 Sino Medical
5.8.1 Profile
5.8.2 PTCA Balloon Business
5.9 Demax Medical (Beijing)
5.9.1 Profile
5.9.2 PTCA Balloon Business

6. Major Foreign Companies
6.1 Medtronic
6.1.1 Profile
6.1.2 Operation
6.1.3 PTCA Balloon Business
6.1.4 Operation in China
6.2 Boston Scientific
6.2.1 Profile
6.2.2 Operation
6.2.3 PTCA Balloon Business
6.2.4 Operation in China
6.3 Abbott
6.3.1 Profile
6.3.2 Operation
6.3.3 PTCA Balloon Business
6.3.4 Operation in China
6.4 Terumo
6.4.1 Profile
6.4.2 Operation
6.4.3 PTCA Balloon Business
6.4.4 Operation in China
6.5 B. Braun Melsungen
6.5.1 Profile
6.5.2 Operation
6.5.3 PTCA Balloon Business
6.5.4 Operation in China

 

图:冠状动脉介入术(PCI)主要使用的器械总图
图:OTW球囊结构示意图
图:单轨/快速交换球囊结构示意图
图:介入医疗器械分类(Classification of Interventional Devices)
图:1985-2013年中国GDP及同比增长率
图:1980-2013年中国卫生费用及所占GDP比重
图:2006-2013E年中国人均卫生费用及同比增长率
图:2004-2013年中国65岁及以上老年人数量及所占总人口比例
表:中国有关医疗器械行业的主要法律、法规
表:与冠脉球囊行业相关的产业政策
表:2012-2013年中国医疗机构数量及床位数
表:2012-2013年中国卫生机构医疗服务量
表:2012-2013年中国卫生机构病床使用情况
图:2005-2013E中国医疗器械行业工业总产值及同比增长
图:2005-2013E中国医疗器械行业销售额及同比增长
图2009-2013年中国国产冠脉药物支架系统市场占有率
图:2011-2013年中国冠脉介入术PCI病例数及增长率
图:2011-2013年中国冠脉支架植入量及DES使用比例
表:2011-2013年中国冠脉球囊需求量
图:2013年中国冠脉支架系统主要品牌及其市场份额(按使用量)
图:2013年进口和国产冠脉球囊导管产品市场份额对比
图:2011-2016E中国冠脉介入术PCI病例数及增长率预测
表: 与介入医疗器械流通使用相关的部分地方性规定
表:2008、2013E中国主要PTCA球囊导管品牌市场价格(单位:元/套)
图:2009-2014年中国假肢、人工器官及介入医疗器械制造业主营收入及利润总额
图:2009-2013年成都市GDP及同比增长率
表:2013年成都市各产业GDP及其占比
图:2009-2013年成都市固定资产投资总额及同比增长率
图:2013年成都市固定资产投资总额产业分布
图:2009-2013年成都市外商直接投资实际使用金额及同比增长率
图:2009-2013年成都市工业总产值及同比增长率
图:2009-2013年成都市工业增加值及同比增长率
表:2013年成都市各产业工业增加值及其占比
图:2009-2013年成都市就业人员平均工资
表:成都工业园一览表
表:成都高新区电费单价
表:成都高新区水费单价
表:成都高新区气费单价
表:成都与上海、香港国际空运价格对比
表:成都与上海国际空运杂费对比
表:成都至上海和深圳铁路运输时间及价格表
图:2005-2013年杭州GDP及同比增长
图:2005-2012年杭州工业总产值及同比增长
图:2005-2013年杭州固定资产投资总额及同比增长
图:2009-2013年杭州在岗职工平均工资
表:杭州开发区一览表
表:杭州经济技术开发区出口加工区与其它地区相比的主要优惠政策
表:杭州经济技术开发区电费单价
表:杭州经济技术开发区水费单价
表:杭州经济技术开发区气费单价
表:国内十万级洁净厂房成本评估(单位:元/平方米)
图:乐普医疗子公司分布
图:2009-2013年乐普医疗营业收入、净利润和毛利率
图:2009-2013年乐普医疗营业收入(分产品)
表:2009-2013年乐普医疗营业收入(分地区)
表:2009-2013年乐普医疗毛利率(分产品)
表:乐普医疗Hoper® PTCA球囊扩张导管技术参数
表:乐普医疗GRIP™耐高压乳突球囊扩张导管型号及参数
表:乐普医疗Nano plus™和Partner ®支架系统配套输送球囊顺应性
表:乐普医疗Biguard™支架系统规格参数
表:乐普医疗Biguard™支架系统配套输送球囊顺应性
表:乐普医疗GuReater™支架系统配套输送球囊顺应性
图:2010-2013年乐普医疗研发支出及占营业收入比
表:乐普医疗募投项目及完成情况
图:2012-2016E乐普医疗营业收入及净利润预测
图:2009-2013年微创医疗营业收入、净利润及毛利率
表:2011-2013年微创医疗营业收入(分产品)
图:2011-2013年微创医疗营业收入构成(分产品)
表:2009-2013年微创医疗营业收入(分地区)
图:2009-2013年微创医疗营业收入构成(分地区)
图:2011-2013年微创医疗心血管介入产品营业收入及占营业收入比
表:微创医疗Pioneer™球囊扩张导管规格参数
表:微创医疗Hercules™球囊扩张导管规格参数
图:2009-2013年微创医疗研发支出及占总营业收入比
图:2012-2016E微创医疗营业收入及净利润预测
表:山东吉威爱克塞尔药物洗脱支架输送系统球囊顺应性
表:垠艺球囊扩张导管特点
表:垠艺预扩系列球囊顺应性
表:垠艺后扩系列球囊顺应性
表:垠艺球囊扩张导管规格型号
表:深圳业聚Sapphire™ Ⅱ球囊扩张导管顺应性
表:深圳业聚Sapphire™冠状动脉球囊扩张导管顺应性
表:深圳业聚Sapphire™ NC高压球囊扩张导管顺应性
表:深圳业聚Scoreflex™双导丝球囊扩张导管顺应性
图:益心达PTCA球囊扩张导管
表:益心达PTCA球囊扩张导管特点及优点
表:益心达PTCA球囊扩张导管技术参数
表:益心达PTCA球囊扩张导管常用规格型号
表:益心达标准型球囊顺应性
表:益心达高压型球囊顺应性
表:心宜医疗Advancer™ PTCA球囊导管主要技术参数
表:心宜医疗Advancer™ PTCA球囊导管球囊顺应性
表:心宜医疗Advancer Plus™ PTCA/CTO球囊导管主要技术参数
表:心宜医疗Advancer Plus™ PTCA/CTO球囊导管球囊顺应性
表:心宜医疗Advancer Hp™ 高压球囊导管主要技术参数
表:心宜医疗Advancer Hp™ 高压球囊导管球囊顺应性
表:赛诺医疗BuMA™输送系统球囊顺应性表
表:赛诺医疗Sleek PTCA快速交换扩张球囊导管规格型号
表:赛诺医疗Sleek PTCA快速交换扩张球囊导管球囊顺应性
图:赛诺医疗Sleek PTCA快速交换扩张球囊导管球囊通过外径示意图
表:北京迪玛克Gusta® PTCA球囊扩张导管技术参数
表:北京迪玛克Gusta® PTCA球囊扩张导管规格型号
表:北京迪玛克Gusta® PTCA球囊扩张导管球囊顺应性
表:北京迪玛克Gusta®NC 非顺应性球囊扩张导管技术参数
表:北京迪玛克Gusta®NC 非顺应性球囊扩张导管规格型号
表:北京迪玛克Gusta®NC 非顺应性球囊扩张导管球囊顺应性
图:2009-2013财年美敦力营业收入及净利润
图:2009-2013财年美敦力营业收入(分产品)
图:2009-2013财年美敦力营业收入构成(分产品)
图:2009-2013财年美敦力冠状动脉产品营业收入及占总营业收入比
表:美敦力Sprinter Legend半顺应性球囊规格
表:美敦力Sprinter OTW 半顺应性球囊规格
表:美敦力NC Sprinter快速交换非顺应性球囊规格
表:美敦力Sprinter Legend OTW半顺应性球囊规格
图:2009-2013年波士顿科学营业收入、净利润及毛利率
表:2009-2013年波士顿科学营业收入(分部门)
表:2009-2013年波士顿科学营业收入(分地区)
图:2009-2013年波士顿科学心血管部门营业收入及同比增长
表:波士顿科学冠脉球囊产品分类、性能组成及适用范围
图:2009-2013年雅培营业收入、净利润及毛利率
图:2009-2013年雅培营业收入(分产品)
图:2009-2013年雅培营业收入构成(分产品)
图:2009-2013年雅培心血管产品营业收入及占总营业收入比
表:雅培TREK&MINI TREK球囊型号及规格
表:雅培NC TREK球囊型号及规格
图:2010-2013财年泰尔茂营业收入及净利润
图:2010-2013财年泰尔茂营业收入(分业务)
图:2010-2013财年泰尔茂营业收入(分地区)
图:2010-2013财年泰尔茂研发投入及占营业收入比
图:2010-2013财年泰尔茂心血管业务营业收入及占总营业收入比
图:2009-2013E财年泰尔茂PTCA冠脉球囊产量及同比增长
表:泰尔茂中国分公司及其主要业务
图:泰尔茂中国布局
图:2009-2013年贝朗营业收入、净利润及毛利率
表:2009-2013年贝朗营业收入(分部门)
表:2009-2013年贝朗营业收入(分地区)
表:贝朗SeQuent® Please PTCA球囊规格及编号
表:贝朗SeQuent® Neo PTCA球囊规格及编号

Main Devices Used for PCI
OTW Balloon Catheter Diagram
Monorail/Rapid Exchange Balloon Catheter Diagram
Classification of Interventional Medical Device
China’s GDP and YoY Growth Rate, 1985-2013
Health Costs and % of GDP in China, 1980-2013
Per Capita Health Costs and YoY Growth Rate in China, 2006-2013E
Number of People 65 and Over and % of Total Population in China, 2004-2013
Laws and Regulations about Medical Device Industry in China
Industry Policies Concerning PTCA Balloon Industry
Number of Medical Institutions and Sickbeds in China, 2012-2013
Medical Service Quantity of Health Care Facilities in China, 2012-2013
Usage of Sickbeds in China’s Medical Institutions, 2012-2013
Total Industrial Output Value and YoY Growth Rate of China Medical Device Industry, 2005-2013E
Sales and YoY Growth Rate of China Medical Device Industry, 2005-2013E
Market Share of Home-made Coronary Drug-eluting Stent System in China, 2009-2013
Number of PCI Cases and Growth Rate in China, 2011-2013
Coronary Stent Implantation and Usage Percentage of Drug-eluting Stent in China, 2011-2013
China’s Demand for PTCA Balloon, 2011-2013
Major Coronary Stent System Brands and Their Market Shares in China (by Consumption), 2013
Market Share Comparison between Home-made and Imported PTCA Balloon, 2013
Number of PCI Cases and Growth Rate in China, 2011-2016E
Local Regulations on Circulation and Usage of Interventional Medical Devices
Market Prices of Major PTCA Balloon Catheter Brands in China, 2008/2013E
Operating Revenue and Total Profit of Artificial Limb, Artificial Organ and Interventional Medical Device Manufacturing, 2009-2014
Chengdu’s GDP and YoY Growth Rate, 2009-2013
Chengdu’s GDP and Percentage by Industry, 2013
Chengdu’s Total Fixed Asset Investment and YoY Growth, 2009-2013
Chengdu’s Total Fixed Asset Investment Breakdown by Industry, 2013
Actual Use of Foreign Direct Investment and YoY Growth in Chengdu, 2009-2013
Chengdu’s Total Industrial Output Value and YoY Growth, 2009-2013
Chengdu’s Industrial Value Added and YoY Growth, 2009-2013
Chengdu’s Industrial Value Added by Sector and Percentage, 2013
Average Wage of Employees in Chengdu, 2009-2013
List of Industrial Parks in Chengdu
Unit Price of Electricity in Chengdu Hi-Tech Industrial Development Zone
Unit Price of Water in Chengdu Hi-Tech Industrial Development Zone
Unit Price of Gas in Chengdu Hi-Tech Industrial Development Zone
International Air Transport Price Comparison between Chengdu and Shanghai & Hong Kong
International Air Transport Incidentals Comparison between Chengdu and Shanghai
List of Time and Prices for Railway Transportation from Chengdu to Shanghai/Shenzhen
Hangzhou’s GDP and YoY Growth, 2005-2013
Hangzhou’s Total Industrial Output Value and YoY Growth, 2005-2012
Hangzhou’s Total Fixed Asset Investment and YoY Growth, 2005-2013
Average Wage of On-post Employees in Hangzhou, 2009-2013
List of Development Zones in Hangzhou
Main Preferential Policies in Export Processing Zone of Hangzhou Economic and Technological Development Zone Compared with Other Regions
Unit Price of Electricity in Hangzhou Economic and Technological Development Zone
Unit Price of Water in Hangzhou Economic and Technological Development Zone
Unit Price of Gas in Hangzhou Economic and Technological Development Zone
Cost Estimation for 100,000-grade Clean Workshop in China
Distribution of Lepu Medical’s Subsidiaries
Revenue, Net Income and Gross Margin of Lepu Medical, 2009-2013
Revenue Breakdown of Lepu Medical (by Product), 2009-2013
Revenue Breakdown of Lepu Medical (by Region), 2009-2013
Gross Margin of Lepu Medical (by Product), 2009-2013
Technical Parameters of Lepu Medical’s Hoper® PTCA Balloon Dilatation Catheter
Models and Parameters of Lepu Medical’s GRIP™ High Pressure Papillary Balloon Dilatation Catheter
Balloon Compliance of Lepu Medical’s Nano plus™ and Partner® Stent Delivery System
Specifications of Lepu Medical’s Biguard™ Stent System
Balloon Compliance of Lepu Medical’s Biguard™ Stent Delivery System
Balloon Compliance of Lepu Medical’s GuReater™ Stent Delivery System
R&D Costs and % of Total Revenue of Lepu Medical, 2010-2013
Projects with Funds from IPO or Refinancing and Completion Status of Lepu Medical
Revenue and Net Income of Lepu Medical, 2012-2016E
Revenue, Net Income and Gross Margin of MicroPort, 2009-2013
Revenue Breakdown of MicroPort (by Product), 2011-2013
Revenue Structure of MicroPort (by Product), 2011-2013
Revenue Breakdown of MicroPort (by Region), 2009-2013
Revenue Structure of MicroPort (by Region), 2009-2013
Revenue from Cardiovascular Interventional Products and % of Total Revenue of MicroPort, 2011-2013
Specifications of MicroPort’s Pioneer™ Balloon Dilatation Catheter
Specifications of MicroPort’s Hercules™ Balloon Dilatation Catheter
R&D Costs and % of Total Revenue of MicroPort, 2009-2013
Revenue and Net Income of MicroPort, 2012-2016E
Balloon Compliance of JW Medical’s EXCEL Drug-eluting Stent Delivery System
Features of Dalian Yinyi’s Balloon Dilatation Catheters
Balloon Compliance of Dalian Yinyi’s Pre-dilatation Balloon Catheter Series
Balloon Compliance of Dalian Yinyi’s Post-dilatation Balloon Catheter Series
Specifications and Models of Dalian Yinyi’s Balloon Dilatation Catheters
Compliance of Neich Medical (Shenzhen)’s Sapphire™ II Balloon Dilatation Catheter
Compliance of Neich Medical (Shenzhen)’s PCTA Balloon Dilatation Catheter
Compliance of Neich Medical (Shenzhen)’s Sapphire™ NC High Pressure Balloon Dilatation Catheter
Compliance of Neich Medical (Shenzhen)’s Scoreflex™ Dual-wire Balloon Dilatation Catheter
SCW Medicath’s PTCA Balloon Dilatation Catheters
Features and Advantages of SCW Medicath’s PTCA Balloon Dilatation Catheters
Technical Parameters of SCW Medicath’s PTCA Balloon Dilatation Catheters
Common Specifications and Models of SCW Medicath’s PTCA Balloon Dilatation Catheters
Compliance of SCW Medicath’s Standard Balloons
Compliance of SCW Medicath’s High Pressure Balloons
Main Technical Parameters of Synexmed’s Advancer™ PTCA Balloon Catheter
Compliance of Synexmed’s Advancer™ PTCA Balloon Catheter
Main Technical Parameters of Synexmed’s Advancer Plus™ PTCA/CTO Balloon Catheter
Balloon Compliance of Synexmed’s Advancer Plus™ PTCA/CTO Balloon Catheter
Main Technical Parameters of Synexmed’s Advancer Hp™ High Pressure Balloon Catheter
Balloon Compliance of Synexmed’s Advancer Hp™ High Pressure Balloon Catheter
Balloon Compliance of Sino Medical’s BuMA™ Delivery System
Specifications and Models of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon
Balloon Compliance of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
Diagram for Balloon Passing External Diameter of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
Technical Parameters of Demax Medical’s Gusta® PTCA Balloon Dilatation Catheter
Specifications and Models of Demax Medical’s Gusta® PTCA Balloon Dilatation Catheter
Balloon Compliance of Demax Medical’s Gusta® PTCA Balloon Dilatation Catheter
Technical Parameters of Demax Medical’s Gusta®NC Noncompliant Balloon Dilatation Catheter
Specifications and Models of Demax Medical’s Gusta®NC Noncompliant Balloon Dilatation Catheters
Balloon Compliance of Demax Medical’s Gusta®NC Noncompliant Balloon Dilatation Catheters
Revenue and Net Income of Medtronic, FY2009-FY2013
Revenue Breakdown of Medtronic (by Product), FY2009-FY2013
Revenue Structure of Medtronic (by Product), FY2009-FY2013
Revenue from Coronary Products and % of Total Revenue of Medtronic, FY2009-FY2013
Specifications of Medtronic’s Sprinter Legend Semicompliant Balloon
Specifications of Medtronic’s Sprinter OTW Semicompliant Balloon
Specifications of Medtronic’s NC Sprinter Rapid Exchange Noncompliant Balloon
Specifications of Medtronic’s Sprinter Legend OTW Semicompliant Balloon
Revenue, Net Income and Gross Margin of Boston Scientific, 2009-2013
Revenue Breakdown of Boston Scientific (by Division), 2009-2013
Revenue Breakdown of Boston Scientific (by Region), 2009-2013
Revenue from Cardiovascular Division and YoY Growth of Boston Scientific, 2009-2013
Classification, Performance and Application of Boston Scientific’s PTCA Balloon
Revenue, Net Income and Gross Margin of Abbott, 2009-2013
Revenue Breakdown of Abbott (by Product), 2009-2013
Revenue Structure of Abbott (by Product), 2009-2013
Revenue from Cardiovascular Products and % of Total Revenue, 2009-2013
Models and Specifications of Abbott’s TREK&MINI TREK Balloon
Models and Specifications of Abbott’s NC TREK Balloon
Revenue and Net Income of Terumo, FY2010-FY2013
Revenue Breakdown of Terumo (by Business), FY2010-FY2013
Revenue Breakdown of Terumo (by Region), FY2010-FY2013
R&D Costs and % of Total Revenue of Terumo, FY2010-FY2013
Revenue from Cardiovascular Business and % of Total Revenue of Terumo, FY2010-FY2013
PTCA Balloon Output and YoY Growth of Terumo, FY2009-FY2013E
Terumo’s Branch Companies in China and Their Main Businesses
Terumo’s Presence in China
Revenue, Net Income and Gross Margin of B. Braun Melsungen, 2009-2013
Revenue Breakdown of B. Braun Melsungen (by Division), 2009-2013
Revenue Breakdown of B. Braun Melsungen (by Region), 2009-2013
Models and Serial Numbers of B. Braun Melsungen’s SeQuent® Please PTCA Balloon
Models and Serial Numbers of B. Braun Melsungen’s SeQuent® Neo PTCA Balloon
    如果这份报告不能满足您的要求,我们还可以为您定制报告,请留言说明您的详细需求。

2005-2010 www.pday.com.cn 版权所有
在线客服系统